Network Partners Group

Executive Summary

Network Partners Group (NPG) is a Boston-based digital health company leveraging AI and machine learning to transform clinical trial operations. Founded in 2015, the company focuses on optimizing trial design, accelerating patient recruitment, and improving operational efficiency for pharmaceutical and biotech sponsors. By addressing critical bottlenecks in drug development, NPG aims to reduce timelines and costs, ultimately bringing therapies to market faster. Its platform uses advanced algorithms to match patients with trials, predict site performance, and automate data analysis, enhancing decision-making for sponsors. Despite a competitive landscape with players like Medidata and IQVIA, NPG differentiates through its niche focus on AI-driven recruitment and trial optimization.

Upcoming Catalysts (preview)

• H2 2026Series B or later funding round closure70% success
• Q1 2027Strategic partnership with top-20 pharma60% success
• TBDFDA or regulatory endorsement of AI trial tool40% success